Advocate Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6M Sell
61,412
-3,413
-5% -$795K 2.34% 6
2026
Q1
$15.8M Sell
64,825
-1,644
-2% -$383K 2.48% 6
2025
Q4
$13.8M Sell
66,469
-3,655
-5% -$723K 2.23% 5
2025
Q3
$13M Buy
70,124
+1,620
+2% +$278K 2.14% 6
2025
Q2
$10.5M Buy
68,504
+3,137
+5% +$482K 1.87% 14
2025
Q1
$10.8M Buy
65,367
+4,414
+7% +$691K 1.98% 9
2024
Q4
$8.81M Buy
60,953
+3,171
+5% +$491K 1.66% 19
2024
Q3
$9.36M Buy
57,782
+1,009
+2% +$161K 1.7% 14
2024
Q2
$8.3M Buy
56,773
+588
+1% +$87.5K 1.67% 19
2024
Q1
$8.89M Buy
56,185
+301
+0.5% +$47.9K 1.77% 14
2023
Q4
$8.76M Sell
55,884
-4,360
-7% -$669K 1.88% 9
2023
Q3
$9.38M Sell
60,244
-6,698
-10% -$1.11M 2.17% 9
2023
Q2
$11.1M Sell
66,942
-3,617
-5% -$584K 2.44% 4
2023
Q1
$10.9M Sell
70,559
-7,884
-10% -$1.27M 2.39% 4
2022
Q4
$13.9M Buy
78,443
+413
+0.5% +$71.3K 2.98% 3
2022
Q3
$12.7M Buy
78,030
+1,003
+1% +$170K 3.15% 3
2022
Q2
$13.7M Buy
+77,027
New +$13.7M 3.18% 3

Other funds holding JNJ

Advocate Group's JNJ Position: Q2 2026 in Review

Advocate Group reduced its Johnson & Johnson (JNJ) stake by 5.3% in Q2 2026, selling an estimated $795K and leaving 61,412 shares worth $15.6M. The position accounts for 2.34% of the portfolio, ranked #6.

Advocate Group first reported a position in JNJ in Q2 2022 and has held it in 17 quarters since. The position peaked at $15.8M in Q1 2026. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Advocate Group held 61,412 shares of Johnson & Johnson worth $15.6M as of Q2 2026.
  • Advocate Group sold 3,413 Johnson & Johnson shares in Q2 2026, an estimated $795K.
  • Johnson & Johnson made up 2.34% of Advocate Group's portfolio in Q2 2026, its #6 holding.
  • Advocate Group first reported a position in Johnson & Johnson in Q2 2022 and has held it in 17 quarters since.
  • Advocate Group's Johnson & Johnson position peaked at $15.8M in Q1 2026.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.